| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.86M | - | |
| VP | 79.5K | $746.2K | - | |
| VP | 67.4K | $632.5K | - | |
| VP | 65.1K | $610.7K | - | |
| VP | 56.3K | $528.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2018 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 12,500 | $18.04 | $225,556.25 | -1.7% | |
| Aug 7, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 12,500 | $18.04 | $225,556.25 | -1.7% | |
| Jul 25, 2018 | Chione Ltd61 | 10% Owner | Sell | 30,039 | $18.65 | $560,134.76 | -0.1% | |
| Jul 20, 2018 | Chione Ltd61 | 10% Owner | Sell | 126,742 | $18.97 | $2,403,744.74 | -0.7% | |
| Jul 18, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 10,000 | $18.27 | $182,686.00 | -1.9% | |
| Jul 18, 2018 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 10,000 | $18.27 | $182,686.00 | -1.9% | |
| Jul 18, 2018 | Chione Ltd61 | 10% Owner | Sell | 50,000 | $18.52 | $926,066.84 | -0.2% | |
| Jul 9, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 12,500 | $18.72 | $233,990.00 | -1.7% | |
| Jul 9, 2018 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 12,500 | $18.72 | $233,990.00 | -1.7% | |
| Jun 18, 2018 | Shacham Sharon79 | President &CSO | Sale+OE | 10,000 | $18.66 | $186,558.00 | -1.9% |